Insight

$Venetoclax and Pegcrisantaspase for Relapsed or Refractory Acute Myeloid Leukemia$

Yuchen Liu/sightmd.com

Nov 2, 2024, 17:34

Venetoclax and Pegcrisantaspase for Relapsed or Refractory Acute Myeloid Leukemia

Anand Patel, Assistant Professor and Director of the Inpatient Leukemia Service at the University of Chicago, shared a recent article by Yuchen Liu on X:

“Very interesting study in Blood Journal looking at Pegcrisantaspase + Ven in R/R AML (68% of patients with prior Ven exposure)!”

$Venetoclax and Pegcrisantaspase for Relapsed or Refractory Acute Myeloid Leukemia$

A phase 1 study of the amino acid modulator pegcrisantaspase and venetoclax in relapsed or refractory acute myeloid leukemia.

Authors: Yuchen Liu, et al.

$Venetoclax and Pegcrisantaspase for Relapsed or Refractory Acute Myeloid Leukemia$

Acute Myeloid Leukemia AML Anand Patel Blood Journal cancer OncoDaily Oncology Pegcrisantaspase venetoclax Yuchen Liu

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Facebook

RSS Feed

Youtube

Insight

Jan 15, 2025, 18:32

MD Anderson Study Reveals Integrated Care as Top Strategy for Smoking Cessation in Lung Screening

Insight

Jan 15, 2025, 18:31

Mehdi Hamadani: Current status of ADCs in lymphoma DLBCL

Blog

Jan 15, 2025, 18:25

Discussion on advancing the Global Cancer Fund at The White House - ASCO

Blog

Jan 15, 2025, 18:19

Antonio Passaro: COCOON study meets primary endpoint

Blog

Jan 15, 2025, 17:58

Felice Gorordo: The White House's round table on the creation of the Global Cancer Fund

Insight

Jan 15, 2025, 17:48

ESO announced the mentorship pairings for 2025

Insight

Jan 15, 2025, 17:38

Baris Turkbey: Impact of Endorectal Coil Use on Extraprostatic Extension Detection in Prostate MRI

Blog

Jan 15, 2025, 17:37

Shalini Rao: Delighted to chair the Gordon Research Seminar on Pancreatic Diseases in Maine

Blog

Jan 15, 2025, 17:33

Exploring the Future of HR+/HER2- MBC Treatment – Live Webinar by SPCC

Insight

Jan 15, 2025, 17:27

Integration of Generative AI into Radiation Therapy practice

Insight

Jan 15, 2025, 17:26

Ajay Major: Summary table of all studies of CAR-T in CNS lymphomas

Insight

Jan 15, 2025, 17:19

Yakup Ergün: A Perspective on the MARS2 Trial by Eric Lim et al